We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

214 hedge funds and large institutions have $376M invested in Nektar Therapeutics in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 68 increasing their positions, 73 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $48K | Put options by funds: $33K

0.25% less ownership

Funds ownership: 6.24% → 5.99% (-0.25%)

7% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 73

7% less funds holding

Funds holding: 230 → 214 (-16)

33% less capital invested

Capital invested by funds: $561M → $376M (-$185M)

34% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 38

Holders
214
Holders Change
-16
Holders Change %
-6.96%
% of All Funds
3.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
68
Reduced
73
Closed
38
Calls
$48K
Puts
$33K
Net Calls
+$15K
Net Calls Change
-$1.77M

Top Buyers

1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$4.95M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.19M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$3.28M
4
ABG
Ally Bridge Group
New York
+$2.91M
5
BlackRock
BlackRock
New York
+$2.84M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$36.4M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$2.47M
3
Primecap Management
Primecap Management
California
-$2.46M
4
Morgan Stanley
Morgan Stanley
New York
-$2.13M
5
State Street
State Street
Massachusetts
-$1.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
201
Steward Partners Investment Advisory
New York
$452 – – –
MCC
202
Money Concepts Capital
Florida
$401 +$290 +6 +100%
HI
203
Harbour Investments
Wisconsin
$350 – – –
NSIM
204
North Star Investment Management
Illinois
$282 – – –
FMII
205
Farmers & Merchants Investments Inc
Nebraska
$255 – – –
DWA
206
Delos Wealth Advisors
Texas
$224 +$339 +7 New
EARNEST Partners
207
EARNEST Partners
Georgia
$188 – – –
ECM
208
Everence Capital Management
Indiana
$67 -$57.8K -1,194 -38%
ASN
209
Advisory Services Network
Georgia
$7 – – –
NA
210
NewEdge Advisors
Louisiana
$4 +$6.15K +127 New
HNB
211
Huntington National Bank
Ohio
$2 – – –
Wellington Management Group
212
Wellington Management Group
Massachusetts
– -$36.4M -758,915 Closed
State of New Jersey Common Pension Fund D
213
State of New Jersey Common Pension Fund D
New Jersey
– -$1.65M -34,394 Closed
GPP
214
Great Point Partners
Connecticut
– -$1.43M -29,855 Closed
JF
215
Jump Financial
Illinois
– -$446K -9,293 Closed
Mirae Asset Global Investments
216
Mirae Asset Global Investments
South Korea
– -$255K -5,314 Closed
Ensign Peak Advisors
217
Ensign Peak Advisors
Utah
– -$220K -4,581 Closed
DTL
218
Dynamic Technology Lab
Singapore
– -$166K -3,464 Closed
QT
219
Quantbot Technologies
New York
– -$152K -3,173 Closed
Marshall Wace
220
Marshall Wace
United Kingdom
– -$100K -2,076 Closed
GD
221
Grandfield & Dodd
New York
– -$80K -1,671 Closed
CAPTRUST Financial Advisors
222
CAPTRUST Financial Advisors
North Carolina
– -$74K -1,537 Closed
CM
223
Caption Management
Oklahoma
– -$67K -1,400 Closed
E
224
Ergoteles
New York
– -$61K -1,279 Closed
PWP
225
Principle Wealth Partners
Connecticut
– -$48 -1,000 Closed
6 7 8
9
10

NKTR Hedge Fund Activity: Q4 2022 in Review

214 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q4 2022, worth a combined $376M — down 33% from $561M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of NKTR and 25 opened new positions — a net loss of 13 holders — while 73 trimmed existing stakes and 68 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $4.95M. The largest seller was Wellington Management Group, exiting entirely with an estimated $36.4M sold.

  • 214 institutional investors held Nektar Therapeutics (NKTR) as of Q4 2022, down from 230 in Q3 2022.
  • Funds reported $376M of Nektar Therapeutics stock for Q4 2022, down 33% quarter-over-quarter.
  • 25 funds opened new Nektar Therapeutics positions in Q4 2022 and 38 closed out, a net change of -13 holders.
  • The largest Nektar Therapeutics buyer in Q4 2022 was Jacobs Levy Equity Management, an estimated $4.95M added.
  • The largest Nektar Therapeutics seller in Q4 2022 was Wellington Management Group, an estimated $36.4M sold.

Based on aggregated 13F filings for Q4 2022.